Loading publications…
The last 5 uploaded publications
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
William HK Schilling, Podjanee Jittamala, James A Watson, Simon Boyd, Viravarn Luvira, Tanaya Siripoon, Thundon Ngamprasertchai, Elizabeth M. Batty, Cintia Cruz, James J. Callery, Shivani Singh, Manisaree Saroj, Varaporn Kruabkontho, Thatsanun Ngernseng, Nuttakan Tanglakmankhong, Jaruwan Tubprasert, Mohammad Yazid Abdad, Wanassanan Madmanee, Jindarat Kouhathong, Kanokon Suwannasin, Watcharee Pagornrat, Nattaporn Piaraksa, Pongtorn Hanboonkunupakarn, Borimas Hanboonkunupakarn, Kittiyod Poovorawan, Manus Potaporn, Attasit Srisubat, Bootsakorn Loharjun, Walter Taylor, Vasin Chotivanich, Kesinee Chotivanich, Mallika Imwong, Sasithon Pukrittayakamee, Arjen M. Dondorp, Nicholas Day, Mauro Martins Teixeira, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Sir Nicholas White, Sir Nicholas White, William HK Schilling, Weerapong Phumratanaprapin, Viravarn Luvira, James J. Callery, Nicholas Day, Sasithon Pukrittayakamee, Simon Boyd, Cintia Cruz, Arjen M. Dondorp, Walter RJ Taylor, James A Watson, Watcharapong Piyaphanee, Kittiyod Poovorawan, Thundon Ngamprasertchai, Tanaya Siripoon, Borimas Hanboonkunupakarn, Kesinee Chotivanich, Podjanee Jittamala, Mallika Imwong, Janjira Thaipadungpanit, Maneerat Ekkapongpisit, Varaporn Kruabkontho, Thatsanun Ngernseng, Jaruwan Tubprasert, Mohammad Yazid Abdad, Elizabeth M. Batty, Shivani Singh, Vasin Chotivanich, Wiroj Ruksakul, Chunlanee Sangketchon, Pongtorn Hanboonkunupakarn, Sakol Sookprome, Mauro Martins Teixeira, Pedro J Almeida, Renato Santana Aguiar, Franciele Santos, Elizabeth A. Ashley, Manivanh Vongsouvath, Koukeo Phommasone, Audrey Dubot‐Pérès, Sisouphanh Vidhamaly, Ammala Chingsanoon, Sixiong Bisayher, Danoy Chommanam, Terry John Evans, Vayouly Vidhamaly, Latsaniphone Boutthasavong, Mayfong Mayxay, Manus Potaporn, Attasit Srisubat, Bootsakorn Loharjun (2023). Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial. The Lancet Infectious Diseases, 24(1), pp. 36-45, DOI: 10.1016/s1473-3099(23)00493-0.
Article144 days agoAntiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
William HK Schilling, Podjanee Jittamala, James A Watson, Simon Boyd, Viravarn Luvira, Tanaya Siripoon, Thundon Ngamprasertchai, Elizabeth M. Batty, Cintia Cruz, James J. Callery, Shivani Singh, Manisaree Saroj, Varaporn Kruabkontho, Thatsanun Ngernseng, Nuttakan Tanglakmankhong, Jaruwan Tubprasert, Mohammad Yazid Abdad, Wanassanan Madmanee, Jindarat Kouhathong, Kanokon Suwannasin, Watcharee Pagornrat, Nattaporn Piaraksa, Pongtorn Hanboonkunupakarn, Borimas Hanboonkunupakarn, Kittiyod Poovorawan, Manus Potaporn, Attasit Srisubat, Bootsakorn Loharjun, Walter Taylor, Vasin Chotivanich, Kesinee Chotivanich, Mallika Imwong, Sasithon Pukrittayakamee, Arjen M. Dondorp, Nicholas Day, Mauro Martins Teixeira, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Sir Nicholas White, Sir Nicholas White, William HK Schilling, Weerapong Phumratanaprapin, Viravarn Luvira, James J. Callery, Nicholas Day, Sasithon Pukrittayakamee, Simon Boyd, Cintia Cruz, Arjen M. Dondorp, Walter RJ Taylor, James A Watson, Watcharapong Piyaphanee, Kittiyod Poovorawan, Thundon Ngamprasertchai, Tanaya Siripoon, Borimas Hanboonkunupakarn, Kesinee Chotivanich, Podjanee Jittamala, Mallika Imwong, Janjira Thaipadungpanit, Maneerat Ekkapongpisit, Varaporn Kruabkontho, Thatsanun Ngernseng, Jaruwan Tubprasert, Mohammad Yazid Abdad, Elizabeth M. Batty, Shivani Singh, Vasin Chotivanich, Wiroj Ruksakul, Chunlanee Sangketchon, Pongtorn Hanboonkunupakarn, Sakol Sookprome, Mauro Martins Teixeira, Pedro J Almeida, Renato Santana Aguiar, Franciele Santos, Elizabeth A. Ashley, Manivanh Vongsouvath, Koukeo Phommasone, Audrey Dubot‐Pérès, Sisouphanh Vidhamaly, Ammala Chingsanoon, Sixiong Bisayher, Danoy Chommanam, Terry John Evans, Vayouly Vidhamaly, Latsaniphone Boutthasavong, Mayfong Mayxay, Manus Potaporn, Attasit Srisubat, Bootsakorn Loharjun (2023). Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial. The Lancet Infectious Diseases, 24(1), pp. 36-45, DOI: 10.1016/s1473-3099(23)00493-0.
Article144 days agoClinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Viravarn Luvira, William HK Schilling, Podjanee Jittamala, James A Watson, Simon Boyd, Tanaya Siripoon, Thundon Ngamprasertchai, Pedro J. Almeida, Maneerat Ekkapongpisit, Cintia Cruz, James J. Callery, Shivani Singh, Runch Tuntipaiboontana, Varaporn Kruabkontho, Thatsanun Ngernseng, Jaruwan Tubprasert, Mohammad Yazid Abdad, Srisuda Keayarsa, Wanassanan Madmanee, Renato Santana Aguiar, Franciele Martins Santos, Pongtorn Hanboonkunupakarn, Borimas Hanboonkunupakarn, Kittiyod Poovorawan, Mallika Imwong, Walter Taylor, Vasin Chotivanich, Kesinee Chotivanich, Sasithon Pukrittayakamee, Arjen M. Dondorp, Nicholas Day, Mauro Martins Teixeira, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Sir Nicholas White (2024). Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial. BMC Infectious Diseases, 24(1), DOI: 10.1186/s12879-023-08835-3.
Article144 days agoCOVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
Sir Nicholas White, James A Watson, Richard M. Hoglund, Xin Hui S Chan, Phaik Yeong Cheah, Joel Tärning (2020). COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology. PLoS Medicine, 17(9), pp. e1003252-e1003252, DOI: 10.1371/journal.pmed.1003252.
Article144 days agoEstimating the Proportion of Plasmodium vivax Recurrences Caused by Relapse: A Systematic Review and Meta-Analysis
Robert J. Commons, J. A. Simpson, James A Watson, Sir Nicholas White, Ric N. Price (2020). Estimating the Proportion of Plasmodium vivax Recurrences Caused by Relapse: A Systematic Review and Meta-Analysis. American Journal of Tropical Medicine and Hygiene, 103(3), pp. 1094-1099, DOI: 10.4269/ajtmh.20-0186.
Article144 days ago